Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

 Gastro/
Procto/
Nutrition		 MICI Pancréas
A. LIEVRE V. VALANTIN I. ROSA P. JOUET S. NAHON V. REBOURS

V. HAUTEFEUILLE
N. WILLIET
N. FARES
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
PE. RAUTOU

H. DAMON
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre décroissant Titre Date Coup de coeur Thématique
Inflammatory Bowel Diseases 2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial mai. 17 2 ♥ MICI
Inflammatory Bowel Diseases Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. oct. 18 3 ♥ Coloproctologie
Inflammatory Bowel Diseases Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review. mai. 17 4 ♥ Coloproctologie
Inflammatory Bowel Diseases Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Cro sep. 17 3 ♥ MICI
Inflammatory Bowel Diseases Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. mai. 16 4 ♥ MICI
Inflammatory Bowel Diseases Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab oct. 17 4 ♥ MICI
Inflammatory Bowel Diseases Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement. oct. 17 4 ♥ Coloproctologie
Inflammatory Bowel Diseases Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy. Jan. 17 2 ♥ MICI
Inflammatory Bowel Diseases Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease juil. 17 3 ♥ MICI
Inflammatory Bowel Diseases The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. fév. 17 2 ♥ MICI
Inflammatory Bowel Diseases Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn’s Disease aoû. 17 3 ♥ MICI
Inflammatory Bowel Diseases Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis. avr. 16 4 ♥ MICI
Inflammatory Bowel Diseases Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease aoû. 16 3 ♥ Intestin/Nutrition/Troubles fonctionnels
Inflammatory Bowel Diseases Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization oct. 15 2 ♥ MICI
Inflammatory Bowel Diseases Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies aoû. 16 3 ♥ MICI
Inflammatory Bowel Diseases Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis aoû. 16 2 ♥ MICI
Inflammatory Bowel Diseases The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure avr. 17 2 ♥ MICI
Inflammatory Bowel Diseases Capsule Endoscopy: Diagnostic Accuracy of Lewis Score in Patients with Suspected Crohn's Disease oct. 15 2 ♥ MICI
Inflammatory Bowel Diseases Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study avr. 17 2 ♥ MICI
Clinical Gastroenterology and Hepatology Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study juin. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. juin. 16 2 ♥ MICI
Clinical Gastroenterology and Hepatology Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. mar. 17 3 ♥ MICI

Pages